Phase 2 Study of SGI-110 in Patients with Higher Risk MDS
The goal of this clinical research study is to learn if SGI-110 can help to control MDS. The safety of this drug will also be studied.
Treatment Location: N/A
IRB Review and Approval Date: 11/10/2014
Recruitment Status: Closed
Projected Accrual: N/A
Information and next steps
For general questions about clinical trials: